Dopamine Infusion in Hypotensive Shock
Start dopamine at 5-10 mcg/kg/min and titrate to effect, but strongly consider norepinephrine as your first-line vasopressor instead, as dopamine is associated with significantly higher rates of arrhythmias and is now relegated to second-line therapy in most shock states.
Initial Dosing Protocol
Starting dose: 5-10 mcg/kg/min IV infusion 1, 2
Titration strategy:
- Increase in 5-10 mcg/kg/min increments as needed
- Maximum effective dose typically 20 mcg/kg/min 1, 2
- Doses >50 mcg/kg/min may cause peripheral, renal, and splanchnic vasoconstriction 3, 2
- If requiring >20 mcg/kg/min, strongly consider switching to norepinephrine 4
Critical Monitoring Requirements
Continuous monitoring is mandatory 4:
- Blood pressure every 5-15 minutes during titration
- Continuous cardiac monitoring for arrhythmias
- Heart rate (watch for tachycardia >120 bpm)
- Urine output hourly
- Arterial line placement recommended as soon as practical 5
- Infusion site inspection frequently for extravasation
Administration Essentials
Infusion setup 2:
- Use volumetric infusion pump (mandatory - never gravity drip)
- Administer through central line when possible
- If peripheral access only: use large bore vein, monitor site continuously for extravasation
- Standard concentration: 400 mg in 500 mL D5W (800 mcg/mL) or 1600-3200 mcg/mL for fluid restriction
Extravasation management: If tissue infiltration occurs, inject phentolamine 0.1-0.2 mg/kg (up to 10 mg) diluted in 10 mL saline intradermally at site 3
Why Dopamine Is Now Second-Line
The evidence strongly favors norepinephrine over dopamine as first-line therapy:
Arrhythmia risk: Dopamine causes significantly more arrhythmic events - 24.1% vs 12.4% with norepinephrine (p<0.001) 6. This finding was replicated in postcardiac surgery patients (25% vs 2%, p=0.009) 7.
Mortality concerns: In cardiogenic shock specifically, dopamine was associated with increased 28-day mortality compared to norepinephrine 6. While overall mortality was similar in septic shock, the arrhythmia burden makes it less desirable.
Current guideline recommendations 5:
- Norepinephrine is the strong recommendation as first-choice vasopressor
- Dopamine relegated to "highly selected patients" only (e.g., absolute/relative bradycardia with low risk of tachyarrhythmias)
- Strong recommendation against low-dose dopamine for renal protection
Specific Clinical Scenarios Where Dopamine May Be Considered
Hypotension with symptomatic bradycardia 1: Dopamine's chronotropic effects may be beneficial when heart rate <60 bpm and pacing unavailable
Anaphylaxis refractory to epinephrine 4: After volume resuscitation and multiple epinephrine doses fail, dopamine 2-20 mcg/kg/min can be used to maintain systolic BP >90 mmHg
Resource-limited settings 8: When norepinephrine unavailable, dopamine remains acceptable alternative
Dose-Dependent Effects
Understanding dopamine's receptor activity guides dosing:
- 2-5 mcg/kg/min: Predominantly dopaminergic (renal/splanchnic vasodilation) - though renal protection benefit is not supported by evidence 1
- 5-10 mcg/kg/min: Beta-adrenergic effects (increased cardiac output, heart rate)
- >10 mcg/kg/min: Alpha-adrenergic effects predominate (vasoconstriction) 3
Common Pitfalls to Avoid
Using dopamine for "renal protection" - This practice is explicitly discouraged by guidelines 1, 5. Low-dose dopamine does not improve renal outcomes.
Inadequate monitoring - Dopamine requires the same intensive monitoring as any potent vasopressor. Never rely on intermittent BP checks alone.
Failure to recognize dopamine resistance early - If requiring >20 mcg/kg/min or developing tachyarrhythmias, switch to norepinephrine promptly. Dopamine resistance predicts 78% mortality vs 16% in responders 9.
Abrupt discontinuation - Taper gradually while expanding blood volume to prevent rebound hypotension 2
Mixing with alkaline solutions - Never add sodium bicarbonate; dopamine is inactivated in alkaline solutions 2
When to Switch Vasopressors
Immediate switch to norepinephrine if:
- New tachyarrhythmias develop
- Heart rate >120-130 bpm
- Dose escalation to 20 mcg/kg/min without adequate response
- Disproportionate rise in diastolic pressure (marked decrease in pulse pressure) 2
The 2016 Surviving Sepsis Campaign guidelines make clear that norepinephrine should be your default first-line agent 5, with dopamine reserved only for the narrow indication of bradycardic shock where its chronotropic effects are specifically desired.